Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy

BACKGROUND: Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors to develop in the digestive tract. These tumors are highly resistant to conventional chemotherapy and only the introduction of imatinib mesylate has improved the prognosis of patients. However, Response Eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Riva, Luca, Bozzi, Fabio, Mondellini, Piera, Miccichè, Francesca, Fumagalli, Elena, Vaghi, Elena, Tarantino, Eva, Huber, Veronica, Gronchi, Alessandro, Tamborini, Elena, Pierotti, Marco A, Pilotti, Silvana, Bongarzone, Italia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192683/
https://www.ncbi.nlm.nih.gov/pubmed/21943129
http://dx.doi.org/10.1186/1479-5876-9-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192683/
https://www.ncbi.nlm.nih.gov/pubmed/21943129
http://dx.doi.org/10.1186/1479-5876-9-158

Ejemplares similares